4//SEC Filing
Mahadevan Chids 4
Accession 0001209191-22-044463
CIK 0001697532other
Filed
Aug 3, 8:00 PM ET
Accepted
Aug 4, 8:38 PM ET
Size
18.1 KB
Accession
0001209191-22-044463
Insider Transaction Report
Form 4
Mahadevan Chids
Chief Accounting Officer
Transactions
- Disposition to Issuer
Employee Stock Option (Right to Buy)
2022-08-02−19,058→ 0 totalExercise: $2.02Exp: 2032-04-13→ Common Stock (19,058 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2022-08-02+7,264→ 7,264 totalExercise: $1.05Exp: 2031-05-10→ Common Stock (7,264 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2022-08-02−7,264→ 0 totalExercise: $17.05Exp: 2031-05-10→ Common Stock (7,264 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2022-08-02−8,824→ 0 totalExercise: $49.60Exp: 2030-01-29→ Common Stock (8,824 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2022-08-02+19,058→ 19,058 totalExercise: $1.05Exp: 2032-04-13→ Common Stock (19,058 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2022-08-02+8,824→ 8,824 totalExercise: $1.05Exp: 2030-01-29→ Common Stock (8,824 underlying)
Footnotes (4)
- [F1]The transaction reported herein reflects a one-time stock option repricing that became effective on August 2, 2022 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934, as amended. There have been no other changes to the terms of these Options.
- [F2]Reflects an initial grant of 19,058 Options granted on April 13, 2022 that vests as follows: One-fourth (1/4th) of the shares subject to the compensatory Option shall vest on April 13, 2023, and one thirty-sixth (1/36th) of the remaining shares subject to the compensatory Option shall vest each month thereafter, subject to the Reporting Person continuing to provide services through each such date.
- [F3]Reflects an initial grant of 13,412 Options granted on May 10, 2021 that vests as follows: One-fourth (1/4th) of the shares subject to the Option were vested upon grant and the remainder of the shares subject to the Option shall vest thereafter in equal monthly installments over the three-year period following the date of grant, subject to the Reporting Person continuing to provide services through each such date.
- [F4]Reflects an initial grant of 14,606 Options granted on January 29, 2020 that vests as follows: One-fourth (1/4) of the shares subject to the Option shall vest on January 30, 2021, and one thirty-sixth (1/36) of the remaining shares subject to the Option shall vest each month thereafter, subject to the Reporting Person continuing to provide services through each such date.
Documents
Issuer
Applied Therapeutics Inc.
CIK 0001697532
Entity typeother
Related Parties
1- filerCIK 0001808486
Filing Metadata
- Form type
- 4
- Filed
- Aug 3, 8:00 PM ET
- Accepted
- Aug 4, 8:38 PM ET
- Size
- 18.1 KB